We aim to develop and commercialize cutting-edge treatments for autoimmune diseases.

​

We are looking for investors and partners to co-develop new

aptamer therapeutics for human autoimmune diseases including rheumatoid arthritis, Graves' disease, lupus and type 1 diabetes.